AC Immune reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of AC Immune using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-05 | $0.06 | $-0.23 | 126.1 % |
Jun 2024 | 2024-08-06 | $-0.25 | $0.31 | -180.7 % |
Mar 2024 | 2024-05-13 | $-0.21 | $-0.15 | -40.0 % |
Dec 2023 | 2024-03-14 | $-0.06 | $-0.13 | 53.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-05 | $29.44M | $1.74M | 1592.1 % |
Mar 2024 | 2024-05-13 | $0 | $6.05M | -100.0 % |
Dec 2023 | 2024-03-14 | $16.69M | $11.44M | 45.9 % |
Jun 2023 | 2023-08-04 | $0 | $1.93M | -100.0 % |
AC Immune ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3.
AC Immune ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3 and the Actual EPS was $0.06, which beat the estimate of $-0.23.
AC Immune ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.